Edition:
United Kingdom

People: Astellas Pharma Inc (4503.T)

4503.T on Tokyo Stock Exchange

1,562JPY
19 Jul 2019
Change (% chg)

¥45 (+2.97%)
Prev Close
¥1,518
Open
¥1,520
Day's High
¥1,562
Day's Low
¥1,518
Volume
4,378,200
Avg. Vol
5,741,279
52-wk High
¥2,056
52-wk Low
¥1,356

Hatanaka, Yoshihiko 

Mr. Yoshihiko Hatanaka has been serving as Chairman of the Board, Chairman of the Board of Directors and Representative Director in Astellas Pharma Inc. since April 1, 2018. His previous titles include President, Director of Business Planning in Main Business Strategy Unit, Executive Officer and Senior Executive Officer in the Company. He previously served as President and Chief Executive Officer in two US-based subsidiaries. He used to work for Fujisawa Pharmaceutical Co., Ltd. He obtained his bachelor's degree in Economics from Hitotsubashi University in May 1980.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --